# Specification Quality Checklist: Prediction/Evidence Collection and Precomputed Adapter

**Purpose**: Validate specification completeness and quality before planning

**Created**: 2026-10-17

**Feature**: [Feature 002 specification](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [ ] No [NEEDS CLARIFICATION] markers remain
- [ ] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [ ] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [ ] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- **Validation result: 12/16 passing.** This is a specification-quality review, not
  implementation verification. Planning is blocked until material ambiguities are resolved.
- User-required existing contract names and versioned JSON are compatibility constraints,
  not a selected implementation stack or new API design. Internal entity meanings do not
  invent external PD fields. Prioritized stories, edge cases and traceability are present.
- **Unresolved markers:** C1 component/contributor mapping authority, C2 external provenance
  admission and C3 missing class mapping. These affect FR-003/005/006/008/015 and conditional
  US2/US3 acceptance; SC-002 admission cases cannot yet be finalized. Thus the no-markers,
  unambiguous-requirements, fully-defined-acceptance and measurable-outcome-readiness gates
  remain unchecked. Do not treat the remaining conditional criteria as approved decisions.
- **Evidence policy review:** FR-011/019 explicitly propose retaining a valid primary
  prediction with missing/invalid optional evidence and safe failure reasons. Confirm that
  policy and association responsibility during clarification; no safety readiness is inferred.
- **Model-agnostic scope review:** Requirements and SC-005 now apply to arbitrary eligible
  registered classifiers and components with different contributor counts, disease/label
  names and algorithms. US2.6/FR-014 explicitly cover different declared source contracts;
  US3.1 and traceability no longer depend on three contributors. Calibration/explanation
  spaces, target semantics, cohort-scope provenance and missing-evidence safeguards remain.
- **Integration example:** PD handoff retained in a non-normative reference section with
  an optional synthetic PD-like scenario. Its actual schema is unavailable; this limits
  direct PD compatibility claims only. Each source requires its own declared contract.
  No model artifact, patient record or clinical dataset was inspected.
- **Revalidation: 12/16 -> 12/16 passing.** No checkbox state changed. C1, C2 and C3 remain
  unanswered and their marker text is unchanged. Feature 001's mandatory class mapping,
  exact identity/compatibility, privacy and separation from safety assessment are preserved.
- These are targeted documentation revisions only. The clarification workflow was not
  run; no questions, answers, architecture plan, application code or tests were introduced.
